Page last updated: 2024-08-17

n,n-dimethyltryptamine and Depression

n,n-dimethyltryptamine has been researched along with Depression in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (14.29)	24.3611
2020's	4 (57.14)	2.80

Authors

Authors	Studies
Araujo, DB; Arcoverde, E; Galvão-Coelho, NL; Palhano-Fontes, F; Soares, BL	1
Gould, TD; Hess, EM	1
Amiri, S; Jahanabadi, S; Karkeh-Abadi, M; Razmi, A	1
Tullis, P	1
Benson, CJ; Cameron, LP; DeFelice, BC; Fiehn, O; Olson, DE	1
Bickel, P; Dittrich, A; Schoepf, J	1
Axelrod, J; Saavedra, JM; Wyatt, RJ	1

Reviews

1 review(s) available for n,n-dimethyltryptamine and Depression

Article	Year
Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters. Fitoterapia, 2023, Volume: 169 Topics: Depression; Hallucinogens; Molecular Structure; N,N-Dimethyltryptamine; Neurotransmitter Agents	2023

Trials

1 trial(s) available for n,n-dimethyltryptamine and Depression

Article	Year
[Altered states of consciousness induced by N,N-dimethyltryptamine (DMT)]. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1976, Volume: 9, Issue:5 Topics: Adult; Anxiety; Attention; Body Image; Cognition Disorders; Consciousness Disorders; Delusions; Depression; Dissociative Disorders; Euphoria; Female; Hallucinations; Humans; Male; Memory Disorders; N,N-Dimethyltryptamine; Tryptamines	1976

Other Studies

5 other study(ies) available for n,n-dimethyltryptamine and Depression

Article	Year
Ayahuasca for the Treatment of Depression. Current topics in behavioral neurosciences, 2022, Volume: 56 Topics: Banisteriopsis; Depression; Hallucinogens; N,N-Dimethyltryptamine	2022
Possible psychedelic therapeutic mechanism. Science (New York, N.Y.), 2023, 02-17, Volume: 379, Issue:6633 Topics: Animals; Depression; Hallucinogens; Humans; N,N-Dimethyltryptamine; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists	2023
How ecstasy and psilocybin are shaking up psychiatry. Nature, 2021, Volume: 589, Issue:7843 Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Drug Prescriptions; Efficiency; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Neuronal Plasticity; Niacin; Psilocybin; Psychiatry; Psychotherapy; Rumination, Cognitive; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic	2021
Chronic, Intermittent Microdoses of the Psychedelic ACS chemical neuroscience, 2019, 07-17, Volume: 10, Issue:7 Topics: Affect; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Extinction, Psychological; Fear; Female; Hallucinogens; Male; N,N-Dimethyltryptamine; Rats; Rats, Sprague-Dawley	2019
A dimethyltryptamine-forming enzyme in human blood. The American journal of psychiatry, 1973, Volume: 130, Issue:7 Topics: Adolescent; Adult; Alcoholism; Blood Platelets; Blood Proteins; Carbon Isotopes; Depression; Erythrocytes; Female; Hallucinogens; Humans; Male; Methylation; Methyltransferases; N,N-Dimethyltryptamine; Psychotic Disorders; Renal Dialysis; S-Adenosylmethionine; Schizophrenia; Tryptamines	1973